2021
DOI: 10.2471/blt.20.270934
|View full text |Cite
|
Sign up to set email alerts
|

Progress towards antibiotic use targets in eight high-income countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…A global action plan on antimicrobial resistance pointed out that high total antibiotic consumption was the main factor leading to the occurrence of AMR and was also the key to controlling the problem [ 29 ]. The current study showed that total antibiotic consumption in Gansu was higher than in some high-income countries and even higher than in France (37% higher) — the country with the highest antibiotic consumption in ESAC before 2017 [ 30 ]. There is no doubt that compared with high-income countries, the disease burden faced by early LMICs (mainly referred to as the burden of infectious disease) was much larger than the adverse effects caused by AMR (burden of AMR bacterial infection).…”
Section: Discussionmentioning
confidence: 99%
“…A global action plan on antimicrobial resistance pointed out that high total antibiotic consumption was the main factor leading to the occurrence of AMR and was also the key to controlling the problem [ 29 ]. The current study showed that total antibiotic consumption in Gansu was higher than in some high-income countries and even higher than in France (37% higher) — the country with the highest antibiotic consumption in ESAC before 2017 [ 30 ]. There is no doubt that compared with high-income countries, the disease burden faced by early LMICs (mainly referred to as the burden of infectious disease) was much larger than the adverse effects caused by AMR (burden of AMR bacterial infection).…”
Section: Discussionmentioning
confidence: 99%
“…In our report, the overall use of the antibacterials from the Access group fell short of the 60% target set by the WHO, ranging from 28.8% in Jordan to 46.7% in Tunisia [ 29 ]. Several high-income countries in Europe and the US reported a median use of 68% from the Access group through enhancing the use of narrow-spectrum antibiotics (France, Germany, Italy, Japan, Spain, Switzerland, United Kingdom, Northern Ireland, and United States of America) [ 30 ]. The use of the Watch group indicates a preference towards using broader spectrum antibacterials.…”
Section: Discussionmentioning
confidence: 99%
“…and Klebsiella pneumoniae in several countries in EMR [ 8 ]. The use of Reserve antibacterials (e.g., colistin) was highest in UAE, Pakistan, and Lebanon (2.3–2.9%), exceeding the reported overall use in high-income countries (1.5%) [ 30 ]. Colistin is the last-resort treatment against multi-drug resistant Gram-negative pathogens and its high use contributes to the global emergence of colistin-resistant pathogens [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have published AWaRe data comparing antibiotic use between and within countries 3 6–13…”
Section: Introductionmentioning
confidence: 99%
“…Some studies report temporal trends in AWaRe data using point-to-point comparisons or linear regression analysis 7–9 11–14. However, these methods assume that data are trending linearly over time, which is unknowable in advance.…”
Section: Introductionmentioning
confidence: 99%